<ѻý>New Drug OK'd for Chemo-Induced Myelosuppression in SCLCѻý> CDK4/6 inhibitor cut the risk for severe neutropenia in small-cell lung cancer patients Feb 13, 2021
<ѻý>CCR Score Could Offer ADT-Free Path in Higher-Risk Prostate Cancerѻý> Large proportion of intermediate- to high-risk patients could avoid aggressive therapy Feb 12, 2021
<ѻý>Survival Boost in Bladder Cancer With Antibody-Drug Conjugateѻý> Four-month absolute improvement with enfortumab vedotin in previously treated disease Feb 12, 2021
<ѻý>Radionuclide Tx Wins in Third-Line Metastatic CRPCѻý> Early trial shows improved PFS, response rates versus cabazitaxel Feb 11, 2021
<ѻý>Hit and Miss in Castration-Resistant Prostate Cancerѻý> No OS benefit with apalutamide-abiraterone, despite improved PFS Feb 11, 2021
<ѻý>Want Data on Recently Approved Actinic Keratosis Drug? Here You Goѻý> Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
<ѻý>First Immunotherapy Approved for Basal Cell Carcinomaѻý> Objective responses in 27% of previously treated patients who received cemiplimab Feb 10, 2021
<ѻý>FDA Panel Slows the Roll for Pembrolizumab in Breast Cancerѻý> Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
<ѻý>Has Pembrolizumab Finally Met an Indication FDA Doesn't Like?ѻý> Agency staff skeptical of data in early breast cancer Feb 08, 2021
<ѻý>Anti-CD20 Drugs Tied to Severe COVID in Cancer Patientsѻý> Plus: Active chemo treatment may not be a COVID risk factor Feb 05, 2021
<ѻý>Brain Tumor Risk Upped With Synthetic Progestogenѻý> Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
<ѻý>Optimizing Neoadjuvant Therapy for Breast Cancerѻý> ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<ѻý>Dustin Diamond's Small Cell Lung Cancerѻý> "Saved by the Bell" actor diagnosed after exhaustive testing Feb 02, 2021
<ѻý>KRAS Inhibitor Continues to Impress in NSCLCѻý> Sotorasib yielded deep and durable responses in over one-third of patients Feb 01, 2021
<ѻý>Nab-Paclitaxel as Possible Option for Relapsed NSCLCѻý> Noninferior to docetaxel for OS, though impact on clinical practice questioned Feb 01, 2021
<ѻý>AGA Updates Guidelines for Refractory H. Pyloriѻý> New info stresses knowing patients' antibiotic exposure and doing drug susceptibility testing Feb 01, 2021
<ѻý>Should COVID-Strained Centers Hit Pause on Lung Cancer Screening?ѻý> A debate on what stopping scans would do to health systems, patients Feb 01, 2021
<ѻý>Promising Data for Preop Checkpoint Inhibition in NSCLCѻý> Major response rate of 21%, encouraging survival with single-agent atezolizumab Jan 31, 2021
<ѻý>First-Ever Survival Bump in Relapsed Mesotheliomaѻý> OS, PFS improved with nivolumab, but questions remain about alternatives, biomarkers Jan 30, 2021
<ѻý>Dual Checkpoint Blockade No Help in PD-L1-High NSCLCѻý> Single-agent pembrolizumab wins out as first-line therapy for advanced disease Jan 30, 2021
<ѻý>COVID Affects Cancer Care, Patients' Mental Healthѻý> Studies: fewer diagnoses, more severe disease, worse outcomes, distressed patients Jan 29, 2021
<ѻý>Preventive Approach to C-Section Bleeding Pans Out in Trialѻý> Treatment lowered risk of early blood loss and transfusion, but not more severe hemorrhage Jan 29, 2021
<ѻý>Whole-Pelvis Tops Prostate-Only RT in High-Risk Diseaseѻý> Practice impact may hinge on knowledge versus clinical bias Jan 28, 2021
<ѻý>Officials Investigate Physician's Death After COVID Vaccinationѻý> Onset of rare blood disorder should not be interpreted as causal, experts say Jan 27, 2021
<ѻý>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻý> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻý>Montana Oncologist Fired for Misdiagnosing, Overtreating Patientsѻý> But some rally around him Jan 26, 2021
<ѻý>Telehealth's Security Problem; Virtual Cancer Care; Post-Pandemic Teladocѻý> Emerging trends in telemedicine and telehealth Jan 25, 2021
<ѻý>Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids?ѻý> News and commentary from the endocrinology world Jan 24, 2021
<ѻý>Aspirin and CRC Risk: A Curious Age Connectionѻý> Implications for prophylactic recommendations, researchers say Jan 21, 2021
<ѻý>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻý> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻý>Kardashian Makeup Artist Hrush Achemyan's Ovarian Cancerѻý> Beauty influencer reveals diagnosis Jan 21, 2021
<ѻý>Oncotype DX Misses on Breast Cancer Risk in Black Womenѻý> Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
<ѻý>Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genesѻý> Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
<ѻý>Preop RT Flunks Test in Borderline Pancreatic Cancerѻý> Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
<ѻý>Drug Hits Target in Advanced Biliary Cancerѻý> Responses in up to a third of patients with FGFR inhibitor infigratinib Jan 19, 2021
<ѻý>Liquid Biopsy Predicts Colon Cancer Relapse Months Before CTѻý> Test for ctDNA outperformed existing biomarker, may help guide therapy Jan 17, 2021
<ѻý>New Target to Attack in Stomach Cancerѻý> PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease Jan 16, 2021
<ѻý>Ethics Consult: Refuse Treatment for Dictator? MD/JD Weighs Inѻý> You voted, now see the results and an expert's discussion Jan 15, 2021
<ѻý>Copay Assistance Programs Help Patients but Confuse Them Tooѻý> Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
<ѻý>Nuanced View of Oral Sex, HPV+ Oropharyngeal Cancerѻý> Age at first oral sex, 'intensity,' number of partners all influence risk Jan 13, 2021